ATUL vs ROSSARI: Stock Comparison

Atul Limited vs Rossari Biotech Limited

Live data: 31 July 2026, 4:08 PM IST • Source: NSE and company filings

Atul Limited is the larger company by market capitalisation. Atul Limited shows a higher ROE, a higher dividend yield and lower leverage, while Rossari Biotech Limited shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Atul Limited and Rossari Biotech Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ATUL is more favourable on 9 of 13 scored metrics and ROSSARI on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ATUL is the larger company
₹19,750 Cr vs ₹2,797 Cr
P/E Ratio
ROSSARI has a lower P/E
18.6x vs 25.32x
P/B Ratio
ROSSARI has a lower P/B
2.1x vs 3.24x
EPS
ATUL has higher earnings per share
₹269.9 vs ₹26.91
Dividend Yield
ATUL has a higher dividend yield
0.44% vs 0.1%
Revenue Growth (TTM YoY)
ROSSARI has faster revenue growth
18.2% vs 15%
EPS Growth (TTM YoY)
ATUL has faster EPS growth
66.1% vs 33.5%
Qtr Sales Growth
ROSSARI has stronger quarterly sales growth
18.2% vs 15%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricATULROSSARI
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricATULROSSARI
Live Price₹6,736.5₹504.3
Day Change-0.98%-0.64%
Volume48,81937,575
52-Week High₹7,180₹713.1
52-Week Low₹5,560.5₹375
Distance from 52W High-6.18%-29.28%

Valuation

MetricATULROSSARI
Market Cap₹19,750 Cr₹2,797 Cr
P/E Ratio25.32x18.6x
P/B Ratio3.24x2.1x
EPS₹269.9₹26.91
Book Value₹2,113.31₹240.75
Dividend Yield0.44%0.1%

Growth

MetricATULROSSARI
Revenue Growth (TTM YoY)15%18.2%
EPS Growth (TTM YoY)66.1%33.5%
Qtr Sales Growth15%18.2%
Qtr Profit Growth66.1%33.5%

Profitability & Leverage

MetricATULROSSARI
ROE11.5%10.8%
ROCE14.9%13.3%
Net Margin10.13%6.14%
Operating Margin16.4%11.9%
Debt to Equity0.03x0.33x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricATULROSSARI
Promoter Holding45.33% 0.11 pp63.63% 0.01 pp
FII Holding7.44% 0.06 pp2.02% 0.16 pp
DII Holding25.93% 0.03 pp14.64% 3.56 pp
Public Holding21.29% 0.09 pp15.2% 3.74 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Atul Limited and Rossari Biotech Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.